Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Return on Equity (2019 - 2025)

Bioadaptives' Return on Equity history spans 7 years, with the latest figure at 0.9% for Q4 2025.

  • Quarterly results put Return on Equity at 0.9% for Q4 2025, up 50.0% from a year ago — trailing twelve months through Dec 2025 was 0.9% (up 50.0% YoY), and the annual figure for FY2025 was 0.87%, up 29.0%.
  • Return on Equity for Q4 2025 was 0.9% at Bioadaptives, up from 0.87% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.91% in Q1 2021 to a low of 0.14% in Q3 2024.
  • The 5-year median for Return on Equity is 0.55% (2022), against an average of 0.54%.
  • The sharpest move saw Return on Equity crashed -51bps in 2023, then surged 72bps in 2025.
  • Year by year, Return on Equity stood at 0.8% in 2021, then dropped by -15bps to 0.68% in 2022, then plummeted by -76bps to 0.17% in 2023, then skyrocketed by 141bps to 0.4% in 2024, then skyrocketed by 126bps to 0.9% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.9%, 0.87%, and 0.59% for Q4 2025, Q3 2025, and Q2 2025 respectively.